Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesGene expression signatures, clinicopathological features, and individualized therapy in breast cancer
JAMA, 04/03/08
Acharya CR et al. - Incorporation of gene expression signatures into clinical risk stratification can refine prognosis
Methods- Retrospective study of early stage breast carcinoma candidates for adjuvant chemotherapy
- Review of microarray data for 964 clinically annotated breast tumor samples (573 in initial set; 391 in validation cohort)
- Relapse risk scores based on respective clinicopathologic features
- Main outcome measures: gene expression signatures and clinicopathological variables in early stage breast cancer to determine a refined estimation of relapse-free survival and sensitivity to chemotherapy
- In initial 573 pts, prognostically significant clusters as patterns of oncogenic pathway activation and tumor biology/microenvironment states were identified within the low-, intermediate-, and high-risk model cohorts
- Multivariate analyses confirmed independent prognostic value of genomic clusters
- Related, not identical, clusters in the independent validation cohort established reproducibility and validity of pathway deregulation patterns in predicting relapse risk
- The prognostic clinicogenomic clusters showed unique sensitivity patterns to commonly used cytotoxic therapies
Related Articles
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers
Journal of Clinical Oncology, 10/29/09
Relevance Score: 74%
Advanced Breast Cancer and Breast Cancer Mortality in Randomized Controlled Trials on Mammography Screening
Journal of Clinical Oncology, 11/09/09
Relevance Score: 72%
Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients
Breast Cancer Research and Treatment, 10/27/09
Relevance Score: 72%
Underweight and breast cancer recurrence and death: A report from the Korean breast cancer society
Journal of Clinical Oncology, 10/08/09
Relevance Score: 72%
Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control study
Cancer Epidemiology, Biomarkers & Prevention, 10/01/09
Relevance Score: 72%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Myeloma cell-induced disruption of bone remodelling compartments leads to osteolytic lesions and generation of osteoclast-myeloma hybrid cells
British Journal of Haematology, 11/20/09
microRNA expression in erythropoiesis and erythroid disorders
British Journal of Haematology, 11/20/09
Purinergic mechanisms in breast cancer support intravasation, extravasation and angiogenesis
Cancer Letters, 11/20/09
Today in Breast...keeping you current
Receive free subspecialty "5-minute updates" via email
Purinergic mechanisms in breast cancer support intravasation, extravasation and angiogenesis
Cancer Letters, 11/20/09
Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors
Molecular Cancer, 11/20/09
Serum estradiol should be monitored not only during the peri-menopausal period but also the post-menopausal period at the time of aromatase inhibitor administration
World Journal of Surgical Oncology, 11/20/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Toxicity of Bisphosphonates
Journal of Palliative Medicine, 11/20/09
Serum estradiol should be monitored not only during the peri-menopausal period but also the post-menopausal period at the time of aromatase inhibitor administration
World Journal of Surgical Oncology, 11/20/09
Lenalidomide, Melphalan, and Prednisone Association Is an Effective Salvage Therapy in Relapsed Plasma Cell Leukaemia
Journal of Oncology, 11/20/09
Sponsor
Article Search
Sponsor
Sponsor